Physician profile
Albert Mcbride
NPI 1093749855
$1,007.55
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $145 · 2021: $391 · 2022: $179 · 2023: $136 · 2024: $14.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $311.35 | 2019-2023 | Myrbetriq, Veozah |
| Myovant Sciences Gmbh | $125.00 | 2021 | |
| Coloplast Corp | $98.28 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.00 | 2021 | |
| Urogen Pharma, INC. | $72.10 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $66.62 | 2022-2024 | Bard Urinary Drainage Bag |
| Axonics, INC. | $44.23 | 2020-2023 | Bulkamid |
| Dentsply Ih INC. | $43.71 | 2020-2021 | |
| Abbvie INC. | $33.57 | 2022 | |
| Endo Pharmaceuticals INC. | $27.69 | 2020-2021 | |
| Smith+Nephew, INC. | $22.53 | 2023 | Stravix |
| Jazz Pharmaceuticals INC. | $20.22 | 2020 | |
| Procept Biorobotics Corporation | $20.20 | 2023 | Aquabeam Robotic System |
| Ambu INC. | $16.61 | 2021 | |
| Sagent Pharmaceuticals | $16.19 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.